Caisse DE Depot ET Placement DU Quebec Has $401,000 Stake in Zoetis Inc. (NYSE:ZTS)

Caisse DE Depot ET Placement DU Quebec boosted its position in shares of Zoetis Inc. (NYSE:ZTS) by 5.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,051 shares of the company’s stock after acquiring an additional 100 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in Zoetis were worth $401,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Mizuho Securities USA LLC lifted its stake in Zoetis by 13,726.9% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company’s stock valued at $950,524,000 after purchasing an additional 4,829,815 shares during the last quarter. Sarasin & Partners LLP raised its stake in Zoetis by 546.3% in the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock valued at $390,682,000 after buying an additional 1,904,899 shares during the period. International Assets Investment Management LLC lifted its position in shares of Zoetis by 41,235.7% in the third quarter. International Assets Investment Management LLC now owns 939,974 shares of the company’s stock valued at $183,652,000 after buying an additional 937,700 shares during the last quarter. Marshall Wace LLP boosted its stake in shares of Zoetis by 7,608.6% during the 2nd quarter. Marshall Wace LLP now owns 835,684 shares of the company’s stock worth $144,874,000 after acquiring an additional 824,843 shares during the period. Finally, Swedbank AB increased its holdings in shares of Zoetis by 56.2% during the 2nd quarter. Swedbank AB now owns 1,946,277 shares of the company’s stock worth $337,407,000 after acquiring an additional 700,398 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research report on Monday. JPMorgan Chase & Co. upped their price target on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Piper Sandler lifted their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Leerink Partners began coverage on shares of Zoetis in a report on Monday. They issued an “outperform” rating and a $215.00 price objective for the company. Finally, BTIG Research raised their target price on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Eleven investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $220.80.

Zoetis Stock Up 0.1 %

Shares of ZTS opened at $176.94 on Wednesday. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The company has a market cap of $79.83 billion, a P/E ratio of 33.26, a P/E/G ratio of 2.71 and a beta of 0.89. The firm has a 50 day simple moving average of $183.16 and a two-hundred day simple moving average of $181.01.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period last year, the company posted $1.36 EPS. Research analysts forecast that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st were given a $0.432 dividend. The ex-dividend date of this dividend was Thursday, October 31st. This represents a $1.73 annualized dividend and a yield of 0.98%. Zoetis’s dividend payout ratio is presently 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.